Market by Product Type, Application, and Country Outlook | Forecast 2022-2028
Triton Market Research
has concluded that the medical enzymes market in North America would grow with
a CAGR of 6.57% in the estimated
period from 2022 to 2028.
Report scope can be customized per your requirements. Request For Customization
The countries scrutinized in this region include:
• The United States
• Canada
An important factor supporting
the market expansion in North America is the presence of market players. These
players are engaged in developing cutting-edge products for medicinal enzymes.
The distribution arrangements and joint ventures among these companies are also
contributing to the market’s growth. Besides, the region reports the highest cancer
cases in North America. Owing to its high prevalence and that of other such
diseases, the medical enzymes market is expected to grow in the coming years.
The market in the
United States is predicted to expand at a rapid rate as a result of rising
health concerns, advances in technology, and intensive research efforts. The
Center for Medicare and Medicaid Services predicts that, by 2028, national
healthcare expenditure in the country would reach nearly $6,2 trillion. Thus,
the medical enzymes market in the US will expand as a result of increased
healthcare spending and advancements in R&D.
The market for medical
enzymes is growing as a result of rising healthcare spending caused by rising
per capita income and health awareness. According to CEIC data, the gross
domestic product (GDP) per person increased to $48029.34 in 2021 from $43814.84
in June 2020 as a result of technological developments, a huge enzyme
manufacturing capacity, and significant investments in enzyme research and
development.
Hydrolase enzymes
function as biochemical catalysts by using water to dissolve a chemical bond,
thus causing the splitting of a bigger molecule into smaller ones. Esterases, including
lipases, peptidases, glycosidases, and nucleosidases, are a few examples of these
enzymes. Due to the digestive actions performed by them, the hydrolase enzymes segment
is anticipated to grow, particularly due to an increase in gastrointestinal and
other health issues.
The report analyzes the market based
on product
type and application. Here, the product type segment
comprises hydrolase, thrombolytic enzyme, digestive
enzyme, and endonuclease.
The prime companies considered in
the medical enzymes market include BBI Solutions, CPC Biotech, Novus, Sanofi
SA, Amano Enzyme, Thermofisher Scientific Inc, DuPont, and Advanced Enzymes.
Codexis is a renowned
name in the field of enzyme engineering. Performance Enzymes and Novel
Biotherapeutics are the two main segments in which the company operates. Codexis
develops proteins that can be used as biocatalysts in the production of
pharmaceuticals, fine chemicals, and enzymes, which are utilized as
biotherapeutics in molecular diagnostics. Some of the company’s global partners
include Merck, GSK, Nestle Health Science, Porton, Novartis, and Kalsec. It is
headquartered in California, the United States.
Key deliverables of the report:
·
Market
CAGR during the forecasting years 2022-2028
·
Detailed
data highlighting key insights, industry components, and market strategies
· Comprehensive
information and estimation of the medical enzymes market revenue growth in
North America and its influence on the parent market
·
In-depth
study of forthcoming trends in consumer behavioral patterns
·
A
meticulous analysis of the competitive landscape, vendor scorecard, and
Porter’s Five Forces Analysis Model
· A
wide-ranging study of factors that will challenge the North America medical
enzymes market’s growth during the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA MEDICAL ENZYMES MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE MEDICAL ENZYMES MARKET
2.2. KEY
INSIGHTS
2.2.1. ADVANCEMENTS
IN ENZYME ENGINEERING
2.2.2. INCREASED
DEMAND IN THE PHARMACEUTICAL SECTOR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. PRICE
2.4.2. QUALITY
2.4.3. USAGE
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.7.1. RESEARCH
AND DEVELOPMENT
2.7.2. OPERATIONS
2.7.3. OUTBOUND
LOGISTICS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. MERGERS
& ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES & DEVELOPMENTS
2.9.3. PARTNERSHIPS
& AGREEMENTS
2.9.4. BUSINESS
EXPANSIONS & DIVESTITURES
2.10. MARKET
DRIVERS
2.10.1. RISING
INVESTMENTS IN RESEARCH AND DEVELOPMENT
2.10.2. RISING
AGING POPULATION AND OCCURRENCE OF CHRONIC DISEASES
2.10.3. INCREASING
APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY
2.11. MARKET
CHALLENGES
2.11.1. STRICT
REGULATIONS
2.11.2. SAFETY
CONCERNS WHILE HANDLING ENZYMES
2.12. MARKET
OPPORTUNITIES
2.12.1. RISING
HEALTH ISSUES AND GROWING AWARENESS
2.12.2. RISING
DEMAND FOR SPECIALTY ENZYMES
3. NORTH
AMERICA MEDICAL ENZYMES MARKET OUTLOOK - BY PRODUCT TYPE
3.1. HYDROLASE
3.1.1. HYALURONIDASE
3.1.2. LYSOZYMES
3.1.3. OTHER
HYDROLASES ENZYMES
3.2. THROMBOLYTIC
ENZYME
3.2.1. STREPTOKINASE
3.2.2. UROKINASE
3.2.3. OTHER
THROMBOLYTIC ENZYMES
3.3. DIGESTIVE
ENZYME
3.3.1. LACTASE
3.3.2. L-ASPARAGINASE
3.3.3. OTHER
DIGESTIVE ENZYMES
3.4. ENDONUCLEASE
3.4.1. BENZONASE
3.4.2. OTHER
ENDONUCLEASES
4. NORTH
AMERICA MEDICAL ENZYMES MARKET OUTLOOK - BY APPLICATION
4.1. DISEASE
TREATMENT
4.2. DIAGNOSTIC
TOOLS
4.3. BIOMEDICAL
RESEARCH
4.4. OTHER
APPLICATIONS
5. NORTH
AMERICA MEDICAL ENZYMES MARKET – COUNTRY OUTLOOK
5.1. UNITED
STATES
5.2. CANADA
6. COMPETITIVE
LANDSCAPE
6.1. BASF
SE
6.2. DUPONT
6.3. ROCHE
HOLDING AG
6.4. NOVOZYMES
6.5. DSM
6.6. SANOFI
SA
6.7. CODEXIS
6.8. ADVANCED
ENZYMES
6.9. AMANO
ENZYME
6.10. BBI
SOLUTIONS
6.11. THERMOFISHER
SCIENTIFIC INC
6.12. CPC
BIOTECH
6.13. NOVUS
6.14. BRAIN
BIOTECH AG
6.15. SEKISUI
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: APPLICATIONS
OF ENZYMES IN PHARMACEUTICALS INDUSTRY
TABLE 3: VENDOR
SCORECARD
TABLE 4: REGULATORY
FRAMEWORK
TABLE 5: LIST OF
MERGERS & ACQUISITIONS
TABLE 6: LIST OF
PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: LIST OF
PARTNERSHIPS & AGREEMENTS
TABLE 8: LIST OF
BUSINESS EXPANSIONS & DIVESTITURES
TABLE 9: MEDICAL
APPLICATION OF VARIOUS ENZYMES
TABLE 10: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
FIGURE 1: KEY BUYING
IMPACT ANALYSIS
FIGURE 2: MARKET
ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 5: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2021 & 2028 (IN %)
FIGURE 7: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 10: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $
MILLION)
FIGURE 11: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2021 & 2028 (IN %)
FIGURE 12: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)
FIGURE 13: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)
FIGURE 14: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $
MILLION)
FIGURE 15: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
FIGURE 16: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2021 & 2028 (IN %)
FIGURE 17: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)
FIGURE 18: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)
FIGURE 19: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $
MILLION)
FIGURE 20: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
FIGURE 21: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY ENDNUCLEASE ENZYME, 2021 & 2028 (IN %)
FIGURE 22: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)
FIGURE 23: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $
MILLION)
FIGURE 24: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 25: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)
FIGURE 26: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)
FIGURE 27: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $ MILLION)
FIGURE 28: NORTH
AMERICA MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 29: NORTH
AMERICA MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 30: UNITED
STATES MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: CANADA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)